IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Journal of Health Sciences and Medicine
  • Volume:5 Issue:3
  • Clinical value of heart type fatty acid binding protein (H-FABP) in acute pulmonary thromboembolism

Clinical value of heart type fatty acid binding protein (H-FABP) in acute pulmonary thromboembolism

Authors : Tuba ALTUĞ, Ayşegül ŞENTÜRK, Murat ALIŞIK, Cemile BİÇER
Pages : 861-867
Doi:10.32322/jhsm.1093848
View : 28 | Download : 14
Publication Date : 2022-05-30
Article Type : Research Paper
Abstract :Introduction: To investigate factors which could possibly be prognostic, to decide on thrombolytic therapy as soon as possible, and to determine the prognostic value of H-FABP, which is a new marker, in pulmonary thromboembolism. Material and Method: In our study, a patient group, consisting of 58 patients diagnosed with PTE and a control group of 30 healthy individuals were investigated. According to their risk of mortality, patients were analyzed in three groups: high, moderate and low. The moderate mortality risk groups were categorized into two groups according to PAP and patients with PAP≥45 mmHg were “Group 1” and PAP<45 mmHg were “Group 2”. Differences in levels of H-FABP and other cardiac prognostic markers between these groups were analyzed. Results: H-FABP level was measured as 507.6±99.3 pg/ml in the control group and 3203.1±2389.3 pg/ml in the patient group. H-FABP level was found to be the highest in the high mortality risk group, and the lowest in the low mortality risk group insert ignore into journalissuearticles values(p<0.001);. Moreover, in the subgroups of moderate mortality risk group, H-FABP levels were significantly higher in group 1 compared to group 2. For the evaluation of other cardiac markers in PTE subgroups, pro-BNP level was the highest in the high mortality risk group, and the lowest in the low mortality risk group. Conclusion: The findings in this study show that, H-FABP is a superior marker in determining the prognosis compared to pro-BNP and troponin. High PAP level is one of the important prognostic markers that should be considered along with the electrocardiography findings.
Keywords : Pulmonary thromboembolism, H FABP, Cardiac enzymes, Prognostic factors, Thrombolytic treatment

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025